About this trial
Persons living with dementia (PLWD) are at significantly increased risk for falls, which are the leading cause of emergency department (ED) visits in this population and contribute to serious injuries, functional decline, and caregiver burden. GAPcareAD is an ED-initiated, caregiver-inclusive intervention designed to address fall risk at the point of care. This multi-site trial will compare GAPcareAD (intervention) to usual care for 350 PLWD and caregivers after a fall.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
Community-dwelling adult (living at home or assisted living) 65 years-old or older presenting to ED after a fall within the last seven days
Fall not due to syncope or external force (i.e., struck by car,assault, intoxication)
Fall not due to serious illness (i.e., stroke, acute myocardial infarction)
Patients have an identified caregiver
Disqualifiers
Living in a nursing home
Patients are admitted to the hospital
Patients who have advanced cancer and/or are in hospice
Patients have presence of injuries that prevent mobilization (i.e. pelvic or lower extremity fractures)
Trial design
Parallel
Treatments tested in this trial
Fall Prevention
Other interventionGAPcareAD - Pharmacists perform medication review and recommend modifying fall risk increasing medication. PTs perform fall risk assessments and tailor recommendations based on fall risk and patient's gait, balance, and mobility impairments. Through purposeful engagement by staff, caregivers are encouraged to contribute to the action plans.
Treatment groups
Trial outcomes
Primary outcomes
Effect of intervention
The primary outcome is the number of fall-related emergency department visits per participant within 6 months after randomization, comparing participants receiving the GAPcareAD intervention verses usual care.
Locations
Sponsors and contacts
Click on the lead sponsor to view all of their trials.
University of Colorado, Denver
Lead sponsor
National Institute on Aging (NIA)
Collaborator
This trial is not recruiting at the moment. You can still explore other options: